MedTrace Logo

Cerebrospinal Fluid Proteom in Dependence of Intranasal Breast Milk

NCT04229693 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-02-11

No results posted yet for this study

Summary

Investigation of the cerebrospinal fluid proteom in preterm infants with posthemorrhagic hydrocephalus in our neonatology center with analysis for modulation of proteom in dependence of breastmilk feeding and way of application such as via gavage tube, oral or nasal application.

Conditions

  • Hydrocephalus in Infants

Interventions

OTHER

no intervention

no intervention, only observational.

Sponsors & Collaborators

  • University Hospital of Cologne

    lead OTHER

Principal Investigators

  • Titus Keller, MD · University of Cologne, Children's Hospital

Eligibility

Min Age
3 Days
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-07
Primary Completion
2021-02-28
Completion
2021-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04229693 on ClinicalTrials.gov